Literature DB >> 21186931

Anhedonia associated with stimulant use and dependence in a population-based sample of American adults.

Adam M Leventhal1, Molly Brightman, Katherine J Ameringer, Jodie Greenberg, Lavonda Mickens, Lara A Ray, Ping Sun, Steve Sussman.   

Abstract

Prior research suggests an association between anhedonia--diminished interest or pleasure in rewarding activities--and stimulant use in selected samples. However, it is unclear whether this association generalizes to the overall population and is consistent across stimulant drug types (amphetamine vs. cocaine) and outcome characteristics (any lifetime use vs. dependence). Questions also remain as to whether the anhedonia-stimulant relationship is unique from covariance with depressed mood, psychiatric disorders, and nonstimulant substance use. The current study addressed these questions by examining anhedonia-stimulant relationships in a cross-sectional population-based sample of 43,093 American adults. Results indicated that lifetime anhedonia and depressed mood each were positively associated with lifetime stimulant use and lifetime dependence among those who reported stimulant use. Anhedonia-stimulant relationships were consistent across amphetamine- and cocaine-related outcomes and distinct from covariance with depressed mood, which exhibited no association over and above the effect of anhedonia. After adjusting for demographic, psychiatric, and nonstimulant substance use characteristics, anhedonia-stimulant associations remained significant, although effect sizes were partially attenuated. Lifetime anhedonia was also more prevalent among respondents who initiated use but did not eventually progress to dependence in comparison with individuals who never once used a stimulant drug. Anhedonia appears to be uniquely associated with lifetime use of cocaine and amphetamines and lifetime progression from use to dependence in the American population. Albeit cross-sectional in nature, these findings add further support to the generalizability and specificity of the anhedonia-stimulant relationship. Future research utilizing longitudinal and experimental designs are warranted to clarify the underpinnings of this association. PsycINFO Database Record (c) 2010 APA, all rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21186931      PMCID: PMC3307593          DOI: 10.1037/a0021964

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  17 in total

1.  A comparison of patterns of methamphetamine and cocaine use.

Authors:  Sara L Simon; Kimberly Richardson; Jennifer Dacey; Susan Glynn; Catherine P Domier; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

2.  Methamphetamine abstinence syndrome: preliminary findings.

Authors:  Thomas F Newton; Ari D Kalechstein; Sonia Duran; Nicolette Vansluis; Walter Ling
Journal:  Am J Addict       Date:  2004 May-Jun

3.  Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.

Authors:  Adam M Leventhal; Christopher W Kahler; Lara A Ray; Kristen Stone; Diane Young; Iwona Chelminski; Mark Zimmerman
Journal:  Am J Addict       Date:  2008 May-Jun

4.  Methamphetamine and cocaine users: differences in characteristics and treatment retention.

Authors:  R Rawson; A Huber; P Brethen; J Obert; V Gulati; S Shoptaw; W Ling
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

5.  Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine.

Authors:  Lescia K Tremblay; Claudio A Naranjo; Laura Cardenas; Nathan Herrmann; Usoa E Busto
Journal:  Arch Gen Psychiatry       Date:  2002-05

6.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

7.  Apathy syndrome in cocaine dependence.

Authors:  Ari D Kalechstein; Thomas F Newton; Anna H Leavengood
Journal:  Psychiatry Res       Date:  2002-01-31       Impact factor: 3.222

Review 8.  The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.

Authors:  E J Khantzian
Journal:  Am J Psychiatry       Date:  1985-11       Impact factor: 18.112

9.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

Authors:  F H Gawin; H D Kleber
Journal:  Arch Gen Psychiatry       Date:  1986-02

10.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

View more
  37 in total

1.  fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history.

Authors:  Hanbing Lu; Svetlana Chefer; Pradeep K Kurup; Karine Guillem; D Bruce Vaupel; Thomas J Ross; Anna Moore; Yihong Yang; Laura L Peoples; Elliot A Stein
Journal:  Neuroimage       Date:  2012-06-01       Impact factor: 6.556

2.  Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal; Jocelyn Cuevas; Kelli Rodgers; Joseph Sass
Journal:  Nicotine Tob Res       Date:  2012-03-01       Impact factor: 4.244

3.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

4.  Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers.

Authors:  Adam M Leventhal; Marcus Munafò; Jennifer W Tidey; Steve Sussman; John R Monterosso; Ping Sun; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

5.  Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.

Authors:  Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty
Journal:  Psychol Health Med       Date:  2018-09-13       Impact factor: 2.423

Review 6.  Substance misuse prevention: addressing anhedonia.

Authors:  Steve Sussman; Adam Leventhal
Journal:  New Dir Youth Dev       Date:  2014

7.  Using a data science approach to predict cocaine use frequency from depressive symptoms.

Authors:  Robert Suchting; Jessica N Vincent; Scott D Lane; Charles E Green; Joy M Schmitz; Margaret C Wardle
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

8.  Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Steven Wadden; Averi Gaines; Agnes Rieger; Robert Gallop; James R McKay; Mary Beth Connolly Gibbons
Journal:  J Subst Abuse Treat       Date:  2018-06-21

9.  Applying behavioral economic theory to problematic Internet use: An initial investigation.

Authors:  Samuel F Acuff; James MacKillop; James G Murphy
Journal:  Psychol Addict Behav       Date:  2018-11

10.  Depressive symptoms as predictors of alcohol problem domains and reinforcement among heavy drinking college students.

Authors:  Samuel F Acuff; Kathryn E Soltis; Matthew T Luciano; Lidia Z Meshesha; Paola Pedrelli; Ashley A Dennhardt; James G Murphy
Journal:  Psychol Addict Behav       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.